HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
POFUT1
protein O-fucosyltransferase 1
Chromosome 20 Β· 20q11.21
NCBI Gene: 23509Ensembl: ENSG00000101346.16HGNC: HGNC:14988UniProt: Q9H488
78PubMed Papers
21Diseases
0Drugs
6Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein O-linked glycosylation via fucoseendoplasmic reticulummembraneregulation of Notch signaling pathwayDowling-Degos diseaseneurodegenerative diseaseskin neoplasmactinic keratosis
✦AI Summary

POFUT1 is a protein O-fucosyltransferase that catalyzes O-linked fucosylation of serine and threonine residues within EGF domains using GDP-fucose as substrate 1. This modification is essential for NOTCH signaling, where initial POFUT1-mediated fucosylation primes substrates for FRINGE-catalyzed extension, enabling optimal ligand binding and canonical NOTCH activation by DLL1 or JAGGED1 2. POFUT1 also fucosylates AGRN to regulate acetylcholine receptor clustering. Dysregulation of POFUT1 underlies multiple diseases: loss-of-function mutations cause Dowling-Degos disease (characterized by hyperpigmentation and follicular papules) and developmental disorders with microcephaly and cardiac defects 34. Conversely, POFUT1 overexpression, driven by copy number variations and epigenetic alterations, promotes tumorigenesis across colorectal, gastric, lung, hepatocellular, and esophageal cancers by hyperactivating NOTCH, Wnt/Ξ²-catenin, and PI3K/AKT/mTOR pathways to enhance proliferation, migration, and EMT while suppressing apoptosis 56. In liver endothelial cells, POFUT1 deletion increases fibrinogen expression through enhanced NOTCH/HES1/STAT3 signaling, exacerbating hepatic fibrosis 7. POFUT1 overexpression is detectable in early-stage tumors and patient sera, positioning it as a promising biomarker and therapeutic target 5.

Sources cited
1
POFUT1 is a protein O-fucosyltransferase that catalyzes O-linked fucosylation of serine and threonine residues within EGF domains using GDP-fucose as substrate .
PMID: 28334865
2
This modification is essential for NOTCH signaling, where initial POFUT1-mediated fucosylation primes substrates for FRINGE-catalyzed extension, enabling optimal ligand binding and canonical NOTCH activation by DLL1 or JAGGED1 .
PMID: 33341260
3
In liver endothelial cells, POFUT1 deletion increases fibrinogen expression through enhanced NOTCH/HES1/STAT3 signaling, exacerbating hepatic fibrosis .
PMID: 38460791
4
Conversely, POFUT1 overexpression, driven by copy number variations and epigenetic alterations, promotes tumorigenesis across colorectal, gastric, lung, hepatocellular, and esophageal cancers by hyperactivating NOTCH, Wnt/Ξ²-catenin, and PI3K/AKT/mTOR pathways to enhance proliferation, migration, and EMT while suppressing apoptosis , .
PMID: 40773107
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜21
Dowling-Degos diseaseOpen Targets
0.72Strong
neurodegenerative diseaseOpen Targets
0.52Moderate
skin neoplasmOpen Targets
0.28Weak
actinic keratosisOpen Targets
0.28Weak
placental retentionOpen Targets
0.26Weak
genetic disorderOpen Targets
0.19Weak
hypertensionOpen Targets
0.14Weak
neoplasmOpen Targets
0.10Weak
colorectal carcinomaOpen Targets
0.10Suggestive
esophageal squamous cell carcinomaOpen Targets
0.10Suggestive
smoking cessationOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.09Suggestive
Abnormality of the skeletal systemOpen Targets
0.09Suggestive
gastric cancerOpen Targets
0.07Suggestive
essential hypertensionOpen Targets
0.07Suggestive
colorectal cancerOpen Targets
0.05Suggestive
cancerOpen Targets
0.05Suggestive
autosomal recessive spondylocostal dysostosisOpen Targets
0.05Suggestive
asthmaOpen Targets
0.04Suggestive
spondylocostal dysostosis 2, autosomal recessiveOpen Targets
0.04Suggestive
Dowling-Degos disease 2UniProt
Pathogenic Variants6
NM_015352.2(POFUT1):c.397C>T (p.Arg133Ter)Pathogenic
POFUT1-related disorder
β˜…β˜†β˜†β˜†2022β†’ Residue 133
NM_015352.2(POFUT1):c.289C>T (p.Gln97Ter)Pathogenic
Dowling-Degos disease 2
β˜…β˜†β˜†β˜†2018β†’ Residue 97
NM_015352.2(POFUT1):c.889_890del (p.Trp297fs)Pathogenic
Dowling-Degos disease 2
β˜†β˜†β˜†β˜†2019β†’ Residue 297
NM_015352.2(POFUT1):c.430G>T (p.Glu144Ter)Pathogenic
Dowling-Degos disease 2|Squamous cell lung carcinoma
β˜†β˜†β˜†β˜†2013β†’ Residue 144
NM_015352.2(POFUT1):c.482del (p.Lys161fs)Pathogenic
Dowling-Degos disease 2
β˜†β˜†β˜†β˜†2013β†’ Residue 161
NM_015352.2(POFUT1):c.246+5delPathogenic
Dowling-Degos disease 2
β˜†β˜†β˜†β˜†
View on ClinVar β†—
Related Genes
RBPJProtein interaction100%FUT8Protein interaction99%NOTCH1Protein interaction97%F7Protein interaction89%PLAGL2Protein interaction80%KIF3BProtein interaction80%
Tissue Expression6 tissues
Liver
100%
Heart
72%
Ovary
53%
Lung
42%
Bone Marrow
35%
Brain
29%
Gene Interaction Network
Click a node to explore
POFUT1RBPJFUT8NOTCH1F7PLAGL2KIF3B
PROTEIN STRUCTURE
Preparing viewer…
PDB5UX6 Β· 2.09 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.64LoF Tolerant
pLIβ“˜
0.20Tolerant
Observed/Expected LoF0.42 [0.28–0.64]
RankingsWhere POFUT1 stands among ~20K protein-coding genes
  • #6,103of 20,598
    Most Researched78
  • #3,360of 5,498
    Most Pathogenic Variants6
  • #4,588of 17,882
    Most Constrained (LOEUF)0.64
Genes detectedPOFUT1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.
PMID: 38460791
J Hepatol Β· 2024
1.00
2
POFUT1 as a cancer biomarker: insights into its oncogenic mechanisms and clinical relevance.
PMID: 40773107
J Mol Med (Berl) Β· 2025
0.90
3
Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations.
PMID: 28334865
Glycobiology Β· 2017
0.80
4
Diseases related to Notch glycosylation.
PMID: 33341260
Mol Aspects Med Β· 2021
0.70
5
Dowling-Degos disease: a review.
PMID: 33368260
Int J Dermatol Β· 2021
0.60